Integrin inhibitor, GLPG0187, Purity ≥98%

Synonym: 1320346-97-1; GLPG 0187; GLPG-0187; (2S)-3-[[2,5-Dimethyl-6-[4-(5,6,7,8-tetrahydro-1,8-naphthyridin-2-yl)piperidin-1-yl]pyrimidin-4-yl]amino]-2-[(4-methoxyphenyl)sulfonylamino]propanoic acid

CAS Number: 1320346-97-1
Compound CID: 53340771

Product Size

1 mg; 5 mg; 10 mg; 50 mg

Price

Datasheet

Datasheet

MSDS

MSDS

Properties

Description

GLPG0187 is an effective cytoskeleton inhibitor, that has the ability to prevent the pathway of cytoskeletal signaling by inhibiting integrin.

Molecular Weight

595.71

Molecular Formula

C₂₉H₃₇N₇O₅S

Form

Lyophilized powder

Purity

≥98%

Titer

Free from inappropriate visible particulates, foreign matter, discoloration, or other defects

Applications

GLPG0187 is a cytoskeletal signaling inhibitor that can be studied extensively for its potential therapeutic applications in the treatment of fibrotic diseases and certain cancers by targeting αvβ6 integrin, which is involved in tissue fibrosis and cancer progression.